Real-world clinical outcomes with poly (adenosine diphosphate [ADP]-ribose) polymerase inhibitors as second-line maintenance therapy in patients with recurrent ovarian cancer in the United States (353)

Saved in:
Bibliographic Details
Published in:Gynecologic oncology 2022-08, Vol.166, p.S180-S181
Main Authors: Matulonis, Ursula, Mirza, Mansoor, Malinowska, Izabela, Perhanidis, Jessica, Woodward, Tatia, Kalilani, Linda
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0090-8258
DOI:10.1016/S0090-8258(22)01575-X